Sequentially immune‐induced antibodies could cross‐neutralize SARS‐CoV‐2 variants

BACKGROUND: The Omicron (B.1.1.529) SARS‐COV‐2 variant has raised serious concerns because of its unprecedented rapid rate of spreading and the fact that there are 36 mutations in the spike protein. Since the vaccine‐induced neutralizing antibody targets are the spike protein, this may lead to the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Qi, Zhou, Shasha, Qi, Feifei, Zhang, Yaqing, Li, Fengdi, Liu, Mingya, Bao, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879626/
https://www.ncbi.nlm.nih.gov/pubmed/35213787
http://dx.doi.org/10.1002/ame2.12216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879626/
https://www.ncbi.nlm.nih.gov/pubmed/35213787
http://dx.doi.org/10.1002/ame2.12216

Ejemplares similares